These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 12955532)

  • 1. The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome.
    Al-Azemi M; Omu FE; Omu AE
    Arch Gynecol Obstet; 2004 Dec; 270(4):205-10. PubMed ID: 12955532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention.
    Kaya H; Sezik M; Ozkaya O
    J Minim Invasive Gynecol; 2005; 12(4):355-8. PubMed ID: 16036198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovulation induction management of PCOS.
    Guzick DS
    Clin Obstet Gynecol; 2007 Mar; 50(1):255-67. PubMed ID: 17304040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preconceptual contraception paradigm: obesity and infertility.
    Nelson SM; Fleming RF
    Hum Reprod; 2007 Apr; 22(4):912-5. PubMed ID: 17172282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of metformin and clomiphene citrate therapy for induction of ovulation in the polycystic ovary syndrome.
    Baran S; Api M; Goksedef BP; Cetin A
    Arch Gynecol Obstet; 2010 Oct; 282(4):439-43. PubMed ID: 20473763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of infertility in polycystic ovary syndrome: a brief update.
    Costello MF; Misso ML; Wong J; Hart R; Rombauts L; Melder A; Norman RJ; Teede HJ
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):400-3. PubMed ID: 22639834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetric outcomes after in vitro fertilization in obese and morbidly obese women.
    Dokras A; Baredziak L; Blaine J; Syrop C; VanVoorhis BJ; Sparks A
    Obstet Gynecol; 2006 Jul; 108(1):61-9. PubMed ID: 16816057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and treatment of anovulatory and unexplained infertility.
    Propst AM; Bates GW
    Obstet Gynecol Clin North Am; 2012 Dec; 39(4):507-19. PubMed ID: 23182557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin in the treatment of clomiphene citrate-resistant women with high BMI and primary infertility: clinical results and reproductive outcome.
    Qublan HS; Malkawi HY
    J Obstet Gynaecol; 2005 Jan; 25(1):55-9. PubMed ID: 16147697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    Fertil Steril; 2008 Mar; 89(3):505-22. PubMed ID: 18243179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.
    Saleh AM; Khalil HS
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):614-21. PubMed ID: 15225184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.
    Elnashar A; Fouad H; Eldosoky M; Saeid N
    Fertil Steril; 2006 Feb; 85(2):511-3. PubMed ID: 16595244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.
    Balen AH; Platteau P; Andersen AN; Devroey P; Sørensen P; Helmgaard L; Arce JC
    BJOG; 2006 Oct; 113(10):1195-202. PubMed ID: 16903840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    Hum Reprod; 2008 Mar; 23(3):462-77. PubMed ID: 18308833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome.
    Mohsen IA
    Gynecol Endocrinol; 2012 Apr; 28(4):269-72. PubMed ID: 21970545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome.
    Eckmann KR; Kockler DR
    Ann Pharmacother; 2009 Jul; 43(7):1338-46. PubMed ID: 19584394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of body weight and metabolic anomalies in ovulation induction].
    Franks S; Hamilton-Fairley D
    Contracept Fertil Sex; 1994 Mar; 22(3):178-9. PubMed ID: 8019608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infertility and pregnancy in women with polycystic ovary syndrome.
    Nader S
    Minerva Endocrinol; 2010 Dec; 35(4):211-25. PubMed ID: 21178917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the best prognostic evidence: an example on prediction of outcome after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
    Eijkemans MJ; Habbema JD; Fauser BC
    Semin Reprod Med; 2003 Feb; 21(1):39-47. PubMed ID: 12806558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.